China Pharma Holdings (CPHI) Other Non Operating Income (2010 - 2011)
China Pharma Holdings' (CPHI) quarterly Other Non Operating Income came in at $256762.0 in Q2 2011, down 68.18% on a YoY basis from $807005.0 in Q2 2010, and down 62.1% quarter-over-quarter from $677498.0 in Q1 2011.
Powered by 
Analysis
China Pharma Holdings (CPHI) Other Non Operating Income (2010 - 2011) Analysis & Trends
China Pharma Holdings (CPHI) has reported Other Non Operating Income for 2 consecutive years, with $256762.0 the latest figure, recorded in Q2 2011.
- For the quarter ending Q2 2011, Other Non Operating Income fell 68.18% year-over-year to $256762.0; the trailing twelve-month figure through Mar 2012 stood at $256762.0 (down 84.97% YoY), and the FY2011 full-year result was $934260.0, down 41.2% from the prior year.
- Other Non Operating Income retreated to $256762.0 in Q2 2011 per CPHI's latest filing, from $677498.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $807005.0 in Q2 2010 and bottomed at -$206308.0 in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2011 | 256,762.00 |
| Mar 31, 2011 | 677,498.00 |
| Dec 31, 2010 | -206,308.00 |
| Sep 30, 2010 | 429,687.00 |
| Jun 30, 2010 | 807,005.00 |